COMPARISON OF EFFICACY OF FIXED-DOSE ROSUVASTATIN PLUS EZETIMIBE COMBINATION THERAPY VERSUS ROSUVASTATIN MONOTHERAPY IN CORONARY ARTERY DISEASE PATIENTS. RMSR. 2025;3(8):539-545. Accessed August 17, 2025. https://www.medscireview.net/index.php/Journal/article/view/1865